🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06937047
Starting soon Not applicable

Efficacy and Safety of Cold Versus Hot Snare Polypectomy for Removal of 4-10 mm Pedunculated Colorectal Polyps

NCT06937047 · tracked via the Priya Life Science China tracker
Sponsor
Shandong University
Phase
Not applicable
Started
2025-05-06
Last updated
2025-04-29

Condition(s) studied

Colorectal Polyps

Investigational drug(s) / intervention(s)

cold snare polypectomyhot snare polypectomy

cold snare polypectomy: Cold snare polypectomy was conducted for the removal of 4-10 mm pedunculated colorectal polyps.

hot snare polypectomy: Hot snare polypectomy was conducted for the removal of 4-10 mm pedunculated colorectal polyps.

Study summary

This was a non-inferiority randomized controlled trial designed to compare the efficacy and safety of cold versus hot snare polypectomy for the removal of 4-10 mm pedunculated colorectal polyps. The primary outcome was delayed postpolypectomy bleeding. The secondary outcomes included immediate postpolypectomy bleeding, procedure time, en bloc resection, complete histologic resection, use of haemostatic clips and perforation rate.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: 1. 18-80 years old, male and female 2. Proposed colonoscopy and colonoscopy detection of at least one 4-10 mm pedunculated colorectal polyp Exclusion Criteria: 1. Contraindication to colonoscopy or polypectomy 2. Use of antiplatelet or anticoagulant drugs within 1 week before polypectomy 3. Alarming signs and symptoms of colorectal cancer (blood in stool, black stool, unexplained anaemia and weight loss, abdominal mass, positive rectal examination; or imaging and laboratory tests highly suspicious for colorectal cancer) or endoscopic manifestations of polyps highly suspicious for high-grade intraepithelial neoplasia or carcinoma 4. Comorbidity with inflammatory bowel disease, colonic polyposis, or active gastrointestinal bleeding 5. Inadequate bowel preparation 6. Pregnant or lactating women 7. Failure to sign the informed consent form 8. Patients deemed ineligible by investigators to enrol in the trial

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Qilu Hospital of Shandong University Jinan Shandong

More Shandong University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06937047 on ClinicalTrials.gov ↗ ← All trials in China